Eva Genesio

Aryl azoles with neuroprotective activity—Parallel synthesis and attempts at target identification

Giuseppe Cocconcelli, Enrica Diodato, Andrea Caricasole et al. · Bioorganic & Medicinal Chemistry · 2007 · 45 citations

Biochemistry, Medicine, Drug Discovery +5

A Scalable Route to the SMO Receptor Antagonist SEN826: Benzimidazole Synthesis via Enhanced in Situ Formation of the Bisulfite–Aldehyde Complex

Matteo Betti, Eva Genesio, G. Marconi et al. · Organic Process Research & Development · 2014 · 24 citations

Benzimidazole Synthesis, Organic Chemistry, Chemistry +16

Design and synthesis of a hybrid series of potent and selective agonists of α7 nicotinic acetylcholine receptor

Arianna Nencini, Cristiana Castaldo, Thomas A. Comery et al. · European Journal of Medicinal Chemistry · 2014 · 21 citations

Biochemistry, Medicine, Nicotine +5

<i>N</i>-[5-(5-Fluoropyridin-3-yl)-1<i>H</i>-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an α7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate

Riccardo Zanaletti, Laura Bettinetti, Cristiana Castaldo et al. · Journal of Medicinal Chemistry · 2012 · 14 citations · Full text

Drug Target, Pharmacotherapy, Pharmaceutical Chemistry +21

Structural Features of the β-CD Complexes with Naringin and its Dihydrochalcone and Aglycon Derivatives by 1H NMR

Giovanni Fronza, Claudio Fuganti, Eva Genesio et al. · Journal of Inclusion Phenomena and Macrocyclic Chemistry · 2002 · 13 citations